Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 146.00
-3.60 (-2.41%)
Aug 15, 2025, 5:29 PM CET
Devyser Diagnostics AB Revenue
Devyser Diagnostics AB had revenue of 67.40M SEK in the quarter ending June 30, 2025, with 26.69% growth. This brings the company's revenue in the last twelve months to 235.10M, up 19.89% year-over-year. In the year 2024, Devyser Diagnostics AB had annual revenue of 216.90M with 28.12% growth.
Revenue (ttm)
235.10M
Revenue Growth
+19.89%
P/S Ratio
10.30
Revenue / Employee
1.99M
Employees
121
Market Cap
2.42B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.31B |
| Getinge AB | 35.50B |
| Medicover AB | 25.22B |
| Camurus AB | 2.27B |
| Asker Healthcare Group AB | 15.88B |
| BioArctic AB | 1.52B |
| Bonesupport Holding AB | 1.06B |